Self-assessment of immediate post-vaccination pain after two different MMR vaccines administered as a second dose in 4- to 6-year-old children
| Autor: | C L von Baeyer, N. Clyti, Chantal Wood, Véronique Abitbol, V. Dejos-Conant, A. Bourrillon |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Self-assessment
Male Pediatrics medicine.medical_specialty Injections Subcutaneous Pain Psychology Child Vaccines Administered MMR vaccine Post vaccination Medicine Humans Multicenter Studies as Topic Child Pain Measurement General Veterinary General Immunology and Microbiology business.industry Incidence (epidemiology) Vaccination Public Health Environmental and Occupational Health Pain scale Infectious Diseases El Niño Child Preschool Physical therapy Molecular Medicine Female Safety business Measles-Mumps-Rubella Vaccine |
| Zdroj: | Vaccine. 23(2) |
| ISSN: | 0264-410X |
| Popis: | The aim of this study was to compare self-reported immediate post-vaccination pain and safety of Priorix versus RORVax in 4- to 6-year-old children receiving their second dose of MMR vaccine, using the Faces Pain Scale-Revised (FPS-R), a validated self-report pain scale recommended by the French National Accreditation Agency and Health Evaluation. A total of 620 children from 28 French pediatricians completed all study procedures. Immediate post-vaccination pain was reported by 17.8% of the subjects in Priorix group (N=309) and by 44.7% of the subjects in RORVax group (N=311) [OR=3.7; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect